Publications of Udo Reichl

Poster (358)

2025
Poster
Piasecka, J., Kupke, S. Y., & Reichl, U.Genetically engineered influenza defective interfering particles with enhanced immune activation potential and antiviral efficacy in vitroPresented at: 9th European Congress of Virology (ECV)Cavtat/Dubrovnik (Croatia), April 27, 2025.
Poster
Piasecka, J., Rüdiger, D., Küchler, J., Kupke, S. Y., & Reichl, U.Molecular basis for the antiviral activity of the influenza defective interfering particle “OP7”Presented at: 34th Annual Meeting of the Society for VirologyHamburg (Germany), March 4, 2025.
Poster
Rüdiger, D., Piasecka, J., Küchler, J., Kupke, S. Y., & Reichl, U.The secrets of “OP7”, an influenza DIP: mathematical model, impact of mutations and antiviral mechanismsPresented at: 34th Annual Meeting of the Society for VirologyHamburg (Germany), March 4, 2025.
Poster
Rüdiger, D., Piasecka, J., Küchler, J., Kupke, S. Y., & Reichl, U.The secrets of “OP7”, an influenza DIP: mathematical model, impact of mutations and antiviral mechanismsPresented at: 9th European Congress of Virology (ECV)Cavtat/Dubrovnik (Croatia), April 27, 2025.
2024
Poster
Dogra, T., Pelz, L., Rüdiger, D., Hein, M. D., Böhme, J., Bälkner, M., Kershaw, O., Marichal-Gallardo, P., Gruber, A., Genzel, Y., Bruder, D., Kupke, S. Y., & Reichl, U.Genetically engineered defective interfering particles for antiviral treatment and vaccinationPresented at: 28th ESACT MeetingEdingburgh (Scotland), June 23, 2024.
Poster
Jacobtorweihe, L., Göbel, S., Wolschek, M., Altomonte, J., Reichl, U., & Genzel, Y.HCD Perfusion of CCX.E10 Quail Cells for Production of Vesicular Stomatitis Virus based oncolytic VaccinePresented at: Vaccine Technology IXLos Cabos (Mexico), May 19, 2024.
Poster
Jacobtorweihe, L., Göbel, S., Wolschek, M., Altomonte, J., Reichl, U., & Genzel, Y.Production of Oncolytic rVSV-NDV in CCX.E10 Quail Cells by HCD Perfusion CulturePresented at: Himmelfahrtstagung on Bioprocess Engineering 2024Regensburg (Germany), May 6, 2024.
Poster
Jacobtorweihe, L., Madeline, B., Léon, A., Genzel, Y., & Reichl, U.Production of Oncolytic Newcastle Disease Virus in EB66 cellsPresented at: 28th ESACT MeetingEdingburgh (Scotland), June 23, 2024.
Poster
Küchler, J., Opitz, P., Jordan, I., Genzel, Y., Benndorf, D., & Reichl, U.Quantification of intracellular influenza A virus proteins shows changes in dynamics related to host cell line and virus seedPresented at: 28th ESACT Meeting Edingburgh (Scotland), June 23, 2024.
Poster
Küchler, J., Opitz, P., Jordan, I., Genzel, Y., Benndorf, D., & Reichl, U.Quantification of intracellular influenza A virus proteins shows changes in dynamics related to host cell line and virus seedPresented at: Himmelfahrtstagung on Bioprocess Engineering 2024Regensburg (Germany), May 6, 2024.
Poster
Pelz, L., Dogra, T., Rüdiger, D., Boehme, J., Kershaw, O., Bruder, D., Kupke, S. Y., & Reichl, U.Defective Interfering Particles of Influenza A Virus As Broad-Spectrum AntiviralsPresented at: 33rd Annual Meeting of the Society for Virology (GfV)Vienna (Austria), March 25, 2023.
Poster
Piasecka, J., Rüdiger, D., Küchler, J., Kupke, S. Y., & Reichl, U.Mechanisms of antiviral action of the influenza defective interfering particle “OP7”Presented at: 33rd Annual Meeting of the Society for Virology (GfV)Vienna (Austria), March 25, 2023.
Poster
Piasecka, J., Rüdiger, D., Küchler, J., Kupke, S. Y., & Reichl, U.Mechanisms of antiviral action of the influenza defective interfering particle “OP7”Presented at: 28th ESACT MeetingEdinburgh (Scotland), June 23, 2024.
Poster
Rüdiger, D., Opitz, P., Kupke, S. Y., & Reichl, U.A two-dimensional model to predict coinfection of influenza A virus with defective interfering particles in tissue-like systemsPresented at: Himmelfahrtstagung on Bioprocess Engineering 2024Regensburg (Germany), May 6, 2024.
Poster
Zinnecker, T. M., Thiele, K., Schmidberger, T., Reichl, U., & Genzel, Y.Influenza A Virus Production following Quality by Design PrinciplesPresented at: Vaccine Technology IXLos Cabos (Mexico), May 19, 2024.
Poster
Zinnecker, T. M., Thiele, K., Schmidberger, T., Reichl, U., & Genzel, Y.Implementation of Quality by Design Principles for Influenza A Virus ProductionPresented at: 28th ESACT MeetingEdingburgh (Scotland), June 23, 2024.
Poster
Zuniga-Banuelos, F. J., Hoffmann, M., Reichl, U., & Rapp, E.In-depth N glycoproteomic analysis reveals strategies to elucidate unanticipated N glycans in the low-abundant human blood plasma N glycoproteomePresented at: 23rd Human Proteome Organization World Congress (HUPO World Congress)Dresden (Germany), October 20, 2024.
2023
Poster
Alcalá Orozco, E. A., Fiebig, T., Mahour, R., Grote, V., Rexer, T., & Reichl, U.Development of a cell-free multi-enzyme cascade for the synthesis of CDP-glycerolPresented at: GlycoBioTec 2023Berlin, Germany, January 17, 2023.
Poster
Alcalá Orozco, E. A., Huber, N., Klamt, S., Rexer, T., & Reichl, U.Development of a cell-free enzymatic cascade for the synthesis of GDP-fucose - modeling and optimizationPresented at: GlycoBioTec 2023Berlin, Germany, January 17, 2023.
Poster
Dogra, T., Pelz, L., Rüdiger, D., Hein, M. D., Baelkner, M., Julia D. Boehme, J. D., Marichal-Gallardo, P., Genzel, Y., Bruder, D., Kupke, S. Y., & Reichl, U.Genetically engineered defective interfering particles of influenza A virus for antiviral treatment and vaccinationPresented at: 32nd Annual Meeting of the Society for Virology (GfV)Ulm (Germany), March 28, 2023.
Go to Editor View